On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Tafalgie Therapeutics's own share of each project, not the project's full budget.
- Horizon Europe€2.5M · 2 projects
Projects
2 EU-funded projects, newest first. Tafalgie Therapeutics led 1 of them as coordinator. Each links to the official record.
- Brain-MuSEAssociated partner
MultiScale Exploration of the Brain
Horizon Europe · 2027–2031 · Project on CORDIS ↗
- TAFALGIECoordinator
The first in-class non-opioid drug for treating moderate, severe, and persistent pain with no addiction nor tolerance
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€2.5Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universite D'Aix MarseilleFrance · 1 shared project
- Centre Hospitalier Regional de Marseille Assistance Publique-Hopitaux MarseilleFrance · 1 shared project
- Multiwave TechnologiesFrance · 1 shared project
- Olea MedicalFrance · 1 shared project
- Mag4healthFrance · 1 shared project
- Vect -Horus SASFrance · 1 shared project
- Brigitte BagnolFrance · 1 shared project
- adalabFrance · 1 shared project
- Fondation Universitaire AMIDEXFrance · 1 shared project
- Consulting Solidaire et CitoyenFrance · 1 shared project
- Université de MontréalCanada · 1 shared project
- Tous ChercheursFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- pharmaceutical drugs
- proteins
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.